Your browser doesn't support javascript.
loading
Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.
Blom, Anna M; Magda, Michal; Kohl, Lisa; Shaughnessy, Jutamas; Lambris, John D; Ram, Sanjay; Ermert, David.
Affiliation
  • Blom AM; Department of Translational Medicine, Medical Protein Chemistry, Lund University, Skåne County Council, Malmö 20502, Sweden.
  • Magda M; Department of Translational Medicine, Medical Protein Chemistry, Lund University, Skåne County Council, Malmö 20502, Sweden.
  • Kohl L; Department of Translational Medicine, Medical Protein Chemistry, Lund University, Skåne County Council, Malmö 20502, Sweden.
  • Shaughnessy J; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605; and.
  • Lambris JD; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Ram S; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605; and.
  • Ermert D; Department of Translational Medicine, Medical Protein Chemistry, Lund University, Skåne County Council, Malmö 20502, Sweden; David.Ermert@med.lu.se.
J Immunol ; 199(11): 3828-3839, 2017 12 01.
Article in En | MEDLINE | ID: mdl-29084837
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Streptococcus pyogenes / Recombinant Fusion Proteins / Staphylococcal Vaccines / Complement Factor H / Sepsis / Immunotherapy Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Immunol Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Streptococcus pyogenes / Recombinant Fusion Proteins / Staphylococcal Vaccines / Complement Factor H / Sepsis / Immunotherapy Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Immunol Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: United States